Last updated on March 2018

Pediatric Peanut Allergy


Brief description of study

A randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability and immunologic effects of HAL-MPE1 subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.

Clinical Study Identifier: TX198894

Contact Investigators or Research Sites near you

Start Over

Cherish Semeski

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK USA
  Connect »